ClinicalTrials.gg

Biological

mRNA COVID-19 Vaccine clinical trials

studies test it
18
open now
3
in phase 3
5
first study started
2021

Keep track of what changes. Save the mRNA COVID-19 Vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

18 studies that test it; most in 2021 (7)

Studies that test mRNA COVID-19 Vaccine, by start year
YearStudies
20217
20223
20234
20243
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
7
Phase 3
5
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 12 · Other 6

Duke University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · CanSino Biologics Inc. (2) · CNBG-Virogin Biotech (Shanghai) Ltd. (2) · Invivyd, Inc. (1) · GlaxoSmithKline (1) · Sanofi Pasteur, a Sanofi Company (1) · Vaccine Company, Inc. (1)

Often tested with

Tested in the same studies.

Ibramvibart (1) · Tacrolimus (1) · Arexvy (1) · 2019-nCoV Vaccine mRNA-1273 (1) · VXCO-100 (1) · Influenza Vaccines (1)

Studies

Open first, then newest update. How each study uses mRNA COVID-19 Vaccine is read from its arms, and is right about nine times in ten.

Testing it · 18

Given in every arm · 1 — mRNA COVID-19 Vaccine is usual care beside what is tested
As the comparator · 4 — what is tested is compared with mRNA COVID-19 Vaccine